These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3033617

  • 1. Dual effects of (D-Ala2,Met5)-enkephalinamide on CRF and ACTH secretion.
    Hashimoto K, Suemaru S, Ono N, Hattori T, Inoue H, Takao T, Sugawara M, Kageyama J, Ota Z.
    Peptides; 1987; 8(1):113-8. PubMed ID: 3033617
    [Abstract] [Full Text] [Related]

  • 2. Effects of (D-ala2, met5)-enkephalinamide and naloxone on ACTH and corticosterone secretion.
    Hashimoto K, Suemaru S, Hattori T, Takao T, Inoue H, Sugawara M, Kageyama J, Ota Z.
    Endocrinol Jpn; 1986 Dec; 33(6):813-20. PubMed ID: 3034557
    [Abstract] [Full Text] [Related]

  • 3. Effect of morphine on hypothalamic corticotropin-releasing factor (CRF) and pituitary-adrenocortical activity.
    Suemaru S, Hashimoto K, Ota Z.
    Endocrinol Jpn; 1986 Aug; 33(4):441-8. PubMed ID: 3024953
    [Abstract] [Full Text] [Related]

  • 4. D-Ala2-Met-enkephalinamide, a potent opioid peptide, alters pituitary-adrenocortical secretion in rats.
    De Souza EB, Van Loon GR.
    Endocrinology; 1982 Nov; 111(5):1483-90. PubMed ID: 6290184
    [Abstract] [Full Text] [Related]

  • 5. Hypothalamo-pituitary-interrenal responses to opioid substances in the trout. II. Effects of morphine and D-Ala2, Met5-enkephalinamide on plasma cortisol titres in vivo.
    Mukherjee S, Baker BI, Bird DJ, Buckingham JC.
    Gen Comp Endocrinol; 1987 Oct; 68(1):40-8. PubMed ID: 2822527
    [Abstract] [Full Text] [Related]

  • 6. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z, Csabafi K, Palotai M, Jászberényi M, Földesi I, Gardi J, Szabó G, Telegdy G.
    Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
    [Abstract] [Full Text] [Related]

  • 7. The Met-enkephalin analog D-Ala2-Met-enkephalinamide decreases the adrenocortical response to ACTH in dispersed rat adrenal cells.
    Guaza C, Borrell J.
    Peptides; 1984 Feb; 5(5):895-7. PubMed ID: 6095218
    [Abstract] [Full Text] [Related]

  • 8. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF).
    Rivier C, Bruhn T, Vale W.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):127-31. PubMed ID: 6323684
    [Abstract] [Full Text] [Related]

  • 9. Effects of treatment with adrenocorticotrophin on the hypothalamo-pituitary-adrenal system.
    Stark E, Kárteszi M, Rappay G, Makara GB.
    J Endocrinol; 1981 Jan; 88(1):131-9. PubMed ID: 6257818
    [Abstract] [Full Text] [Related]

  • 10. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA.
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [Abstract] [Full Text] [Related]

  • 11. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.
    Buckingham JC, Cooper TA.
    Neuroendocrinology; 1984 May; 38(5):411-7. PubMed ID: 6328347
    [Abstract] [Full Text] [Related]

  • 12. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain.
    Owens MJ, Edwards E, Nemeroff CB.
    Eur J Pharmacol; 1990 Nov 06; 190(1-2):113-22. PubMed ID: 1963847
    [Abstract] [Full Text] [Related]

  • 13. Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats.
    Suemaru S, Hashimoto K, Ota Z.
    Acta Med Okayama; 1985 Dec 06; 39(6):463-70. PubMed ID: 3004111
    [Abstract] [Full Text] [Related]

  • 14. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J, Grino M, Bernet F, Dutriez-Casteloot I, Montel V, Dupouy JP.
    J Neuroendocrinol; 1998 May 06; 10(5):331-42. PubMed ID: 9663647
    [Abstract] [Full Text] [Related]

  • 15. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.
    Wilson MA, Biscardi R, Smith MD, Wilson SP.
    J Pharmacol Exp Ther; 1996 Sep 06; 278(3):1073-82. PubMed ID: 8819488
    [Abstract] [Full Text] [Related]

  • 16. Role of corticotropin-releasing hormone in gastrin-releasing peptide-mediated regulation of corticotropin and corticosterone secretion in male rats.
    Garrido MM, Martin S, Ambrosio E, Fuentes JA, Manzanares J.
    Neuroendocrinology; 1998 Aug 06; 68(2):116-22. PubMed ID: 9705578
    [Abstract] [Full Text] [Related]

  • 17. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ, Knight DL, Ritchie JC, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Feb 06; 256(2):787-94. PubMed ID: 1847212
    [Abstract] [Full Text] [Related]

  • 18. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ, Knight DL, Ritchie JC, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Feb 06; 256(2):795-800. PubMed ID: 1847213
    [Abstract] [Full Text] [Related]

  • 19. Effects of lithium on the hypothalamo-pituitary-adrenal axis.
    Sugawara M, Hashimoto K, Hattori T, Takao T, Suemaru S, Ota Z.
    Endocrinol Jpn; 1988 Oct 06; 35(5):655-63. PubMed ID: 2851438
    [Abstract] [Full Text] [Related]

  • 20. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug 06; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.